Miller Fisher syndrome and polyneuritis cranialis in COVID-19
Синдром Миллера—Фишера и краниальный полиневрит при COVID-19
2020-04-17
SCID: 54.1/2fgn3skm
Discuss with AI
COVID-19Miller Fisher syndromeSARS-CoV-2albuminocytologic dissociationpolyneuritis cranialis
Figures from the paper
Abstract (AI)
OBJECTIVE: To report 2 patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who presented acutely with Miller Fisher syndrome and polyneuritis cranialis, respectively. METHODS: Patient data were obtained from medical records from the University Hospital "Príncipe de Asturias," Alcalá de Henares, and the University Hospital "12 de Octubre," Madrid, Spain. RESULTS: A 50-year-old man presented with anosmia, ageusia, right internuclear ophthalmoparesis, right fascicular oculomotor palsy, ataxia, areflexia, albuminocytologic dissociation, and positive testing for anti-GD1b-immunoglobulin G antibody. Five days previously, he had developed a cough, malaise, headache, low back pain, and fever. A 39-year-old man presented with ageusia, bilateral abducens palsy, areflexia, and albuminocytologic dissociation. Three days previously, he had developed diarrhea, a low-grade fever, and poor general condition. Oropharyngeal swab test for SARS-CoV-2 by qualitative real-time reverse transcriptase PCR assay was positive in both patients and negative in the CSF. The first patient was treated with IV immunoglobulin and the second with acetaminophen. Two weeks later, both patients made a complete neurologic recovery, except for residual anosmia and ageusia in the first case. CONCLUSIONS: Our 2 cases highlight the rare occurrence of Miller Fisher syndrome and polyneuritis cranialis during the coronavirus disease 2019 (COVID-19) pandemic. These neurologic manifestations may occur because of an aberrant immune response to COVID-19. The full clinical spectrum of neurologic symptoms in patients with COVID-19 remains to be characterized.
Key Findings
1
Both patients achieved complete neurological recovery within two weeks, except for persistent anosmia and ageusia in the Miller Fisher syndrome case.
2
SARS-CoV-2 PCR was positive in oropharyngeal samples but negative in cerebrospinal fluid in both patients, supporting an indirect immune-mediated mechanism.
3
The Miller Fisher syndrome case featured ophthalmoparesis, ataxia, areflexia, albuminocytologic dissociation, and anti-GD1b IgG antibodies.
4
The polyneuritis cranialis case presented with bilateral abducens palsy, areflexia, and albuminocytologic dissociation.
5
Two SARS-CoV-2-infected patients developed acute postinfectious cranial neuropathies: one Miller Fisher syndrome and one polyneuritis cranialis.
Research Object
Miller Fisher syndrome and polyneuritis cranialis in patients infected with SARS-CoV-2
Research Subject
Acute neurologic manifestations and their possible association with an aberrant immune response to COVID-19
Publication Details
Publication Date
2020-04-17
Journal
Publisher
ISSN
Cited by
816
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai1
Cited by8
Neurological associations of COVID-192020
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-22020
Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic2020
Neurological complications and infection mechanism of SARS-CoV-22021
SARS‐CoV‐2 and the brain: A review of the current knowledge on neuropathology in COVID‐192021
Miller‐Fisher syndrome after SARS‐CoV‐2 infection2020
Miller Fisher syndrome: an updated narrative review2023
Miller Fisher Syndrome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic Review2021